Clinical Trial Update: S0800, Nab-Paclitaxel, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating nab-paclitaxel with doxorubicin, cyclophosphamide, and pegfilgrastim, with or without bevacizumab, in women with inflammatory or loca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Inflammatory Breast Cancer

Drugs mentioned

• Abraxane (paclitaxel albumin-bound)
• Adriamycin (doxorubicin)
• Avastin (bevacizumab)
• Cytoxan (cyclophosphamide)
• NEULASTA (pegfilgrastim)

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2017-06-27